News and Noteworthy
News and Noteworthy
CTRU Medical Hero Appreciation and Awareness Day- April 13, 2019
Thank you to all who made it out to the CTRU Medical Hero Appreication and Awareness Day. Be sure to follow us on facebook for future events and more information on current research happening at Ohio University!
CTRU's 2018 Year in Review
Heritage College, CTRU and OhioHealth join international drug study
A large-scale clinical drug trial in which our college is playing a role could help prevent deaths from heart attack and stroke. Kowa Pharmaceuticals America, I nc., is sponsoring a study of a cholesterol-lowering fibrate drug, to find out how effective it is in reducing these types of life-threatening cardiovascular events. The study, which aims to enroll around 10,000 subjects, will take place at sites in 20 different countries – and will include the Heritage College and its partner OhioHealth.
Vipin Koshal, D.O. (’01), assistant clinical professor of specialty medicine and OhioHealth cardiologist, is principal investigator for the local portion of the clinical trial, and Amber Healy, D.O. (’09), assistant clinical professor of specialty medicine, OhioHealth diabetologist and director of our diabetes fellowship program, is a co-investigator. The research here is supported by the Ohio University Clinical & Translational Reseach Unit. For the full news article, please click here.
American Heart Association funds research into how obesity affects sugar metabolism
More than half of Americans drink at least one sugary beverage a day, despite the known negative health effects. For those with obesity, the impact is even greater. With support from the American Heart Association, Heritage College faculty member Leslie Consitt, Ph.D., is studying how obesity may be linked at the cellular level to “metabolic inflexibility” – a reduction in the body’s ability to metabolize sugar.
With help from the Ohio University Clinical & Translational Research Unit, Dr. Consitt is looking at the cellular pathways that are responsible for glucose metabolism, to see how they differ between obese individuals and lean, healthy individuals when they each consume a sugary drink. What she learns may have significant implications for patients at risk for cardiovascular disease and type 2 diabetes. For the ful news article, please click here.
Connect with the CTRU on Facebook
After much anticipation, the Clinical & Translational Research Unit is live on social media! Connect with us to stay up to date on current events, medical advances and research, healthy tips and recipes, volunteer opportunities, and our CTRU team. Check us out at www.facebook.com/OhioUniversityCTRU or by clicking the logo to the left.